You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Antithrombotic Therapy: Highlights From ESC 2017

August 26-30, 2017

Barcelona, Spain


Educational Activities

Supported by

Bayer AG

  • COMPASS For patients with stable atherosclerotic vascular disease, rivaroxaban 2.5 mg twice daily plus aspirin had better CV outcomes than aspirin alone.
  • XANTUS How are NOACs being used in the real world? Studies such as XANTUS provide an insight.
  • RE-DUAL PCI For AF patients undergoing PCI, bleeding risk was lower in those receiving dabigatran and a P2Y12 inhibitor vs triple therapy.
  • EMANATE Apixaban lowers the risk of stroke vs warfarin in patients with AF scheduled for elective cardioversion.
  • IMPACT-AF This multifaceted and multilevel educational intervention improved use of oral anticoagulation in patients with AF and at risk for stroke.
  • REHEARSE-AF Twice-weekly screening with an iECG in patients ≥65 years at risk of stroke is significantly more likely to identify incident AF than routine care.